CSIS's Morrison discusses 'end of aids'

NewsGuard 100/100 Score
Jan 6 2012

SmartGlobalHealth.org features the latest episode of "Small Screen Sessions," in which J. Stephen Morrison, director of the Center for Strategic & International Studies' Global Health Policy Center, discusses the policy changes that enabled the International AIDS Conference to return to the U.S. in 2012 after a 22-year hiatus, and the beginning of the "end of aids" (1/4).

    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Posted in: Disease/Infection News | Healthcare News

    Tags: , , ,

    Comments (0)

    Suggested Reading

    Rethinking the germ theory: A balanced take on microbes and disease outcomes
    American Heart Association report highlights disparities in heart disease, calls for equitable healthcare
    Exploring the role of iodine in obesity, diabetes, and other metabolic conditions
    MONET: New AI tool enhances medical imaging with deep learning and text analysis
    Closing the Cancer Care Gap with the Power of Precision Oncology
    Revolutionary CAR T-cell therapy shows promise in reversing age-related metabolic dysfunction
    Nicotine patches and e-cigarettes in pregnancy: A deep dive into risks and outcomes
    Belief in caffeine improves running performance

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    (Logout)
    Post

    Newsletters you may be interested in

    See all Newsletters »

    Terms

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    Provide Feedback

    You might also like...
    ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing